Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891882983> ?p ?o ?g. }
- W2891882983 abstract "MM cells express high levels of CD38, while CD38 is expressed at relatively low levels on normal lymphoid and myeloid cells, and in some non-hematopoietic tissues. This expression profile, together with the role of CD38 in adhesion and as ectoenzyme, resulted in the development of CD38 antibodies for the treatment of multiple myeloma (MM). At this moment several CD38 antibodies are at different phases of clinical testing, with daratumumab already approved for various indications both as monotherapy and in combination with standards of care in MM. CD38 antibodies have Fc-dependent immune effector mechanisms, such as complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC), and antibody-dependent cellular phagocytosis (ADCP). Inhibition of ectoenzymatic function and direct apoptosis induction may also contribute to the efficacy of the antibodies to kill MM cells. The CD38 antibodies also improve host-anti-tumor immunity by the elimination of regulatory T cells, regulatory B cells, and myeloid-derived suppressor cells. Mechanisms of primary and/or acquired resistance include tumor-related factors, such as reduced cell surface expression levels of the target antigen and high levels of complement inhibitors (CD55 and CD59). Differences in frequency or activity of effector cells may also contribute to differences in outcome. Furthermore, the microenvironment protects MM cells to CD38 antibody-induced ADCC by upregulation of anti-apoptotic molecules, such as survivin. Improved understanding of modes of action and mechanisms of resistance has resulted in rationally designed CD38-based combination therapies, which will contribute to further improvement in outcome of MM patients." @default.
- W2891882983 created "2018-09-27" @default.
- W2891882983 creator A5069712875 @default.
- W2891882983 creator A5083639923 @default.
- W2891882983 date "2018-09-20" @default.
- W2891882983 modified "2023-10-17" @default.
- W2891882983 title "CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance" @default.
- W2891882983 cites W1504562963 @default.
- W2891882983 cites W1528751727 @default.
- W2891882983 cites W1540943134 @default.
- W2891882983 cites W1585625390 @default.
- W2891882983 cites W1600286956 @default.
- W2891882983 cites W1902692042 @default.
- W2891882983 cites W1916436059 @default.
- W2891882983 cites W1938402249 @default.
- W2891882983 cites W1967198288 @default.
- W2891882983 cites W1968884620 @default.
- W2891882983 cites W1985960971 @default.
- W2891882983 cites W1990518937 @default.
- W2891882983 cites W1994013901 @default.
- W2891882983 cites W2000748318 @default.
- W2891882983 cites W2010232494 @default.
- W2891882983 cites W2010614363 @default.
- W2891882983 cites W2016216971 @default.
- W2891882983 cites W2023082289 @default.
- W2891882983 cites W2039853192 @default.
- W2891882983 cites W2044360617 @default.
- W2891882983 cites W2046614465 @default.
- W2891882983 cites W2056376654 @default.
- W2891882983 cites W2067577146 @default.
- W2891882983 cites W2069524809 @default.
- W2891882983 cites W2072259475 @default.
- W2891882983 cites W2075901113 @default.
- W2891882983 cites W2086870979 @default.
- W2891882983 cites W2090083883 @default.
- W2891882983 cites W2091057822 @default.
- W2891882983 cites W2092716754 @default.
- W2891882983 cites W2102942531 @default.
- W2891882983 cites W2109502548 @default.
- W2891882983 cites W2113261463 @default.
- W2891882983 cites W2113262521 @default.
- W2891882983 cites W2114101532 @default.
- W2891882983 cites W2119661337 @default.
- W2891882983 cites W2119904228 @default.
- W2891882983 cites W2122367718 @default.
- W2891882983 cites W2123895023 @default.
- W2891882983 cites W2130867811 @default.
- W2891882983 cites W2130930654 @default.
- W2891882983 cites W2133119201 @default.
- W2891882983 cites W2136877606 @default.
- W2891882983 cites W2141502099 @default.
- W2891882983 cites W2153048580 @default.
- W2891882983 cites W2153255423 @default.
- W2891882983 cites W2154985186 @default.
- W2891882983 cites W2162771614 @default.
- W2891882983 cites W2164073959 @default.
- W2891882983 cites W2167085850 @default.
- W2891882983 cites W2168195228 @default.
- W2891882983 cites W2171626043 @default.
- W2891882983 cites W2182681254 @default.
- W2891882983 cites W2229483068 @default.
- W2891882983 cites W2253038466 @default.
- W2891882983 cites W2309431784 @default.
- W2891882983 cites W2329974159 @default.
- W2891882983 cites W2346831633 @default.
- W2891882983 cites W2400276917 @default.
- W2891882983 cites W2402003835 @default.
- W2891882983 cites W2439803058 @default.
- W2891882983 cites W2443548094 @default.
- W2891882983 cites W2499492956 @default.
- W2891882983 cites W2512106959 @default.
- W2891882983 cites W2517949488 @default.
- W2891882983 cites W2526413860 @default.
- W2891882983 cites W2528329272 @default.
- W2891882983 cites W2529484267 @default.
- W2891882983 cites W2530394087 @default.
- W2891882983 cites W2537387853 @default.
- W2891882983 cites W2552397723 @default.
- W2891882983 cites W2553693801 @default.
- W2891882983 cites W2588591261 @default.
- W2891882983 cites W2588885669 @default.
- W2891882983 cites W2592248309 @default.
- W2891882983 cites W2592848966 @default.
- W2891882983 cites W2593030375 @default.
- W2891882983 cites W2598343734 @default.
- W2891882983 cites W2606701234 @default.
- W2891882983 cites W2607519434 @default.
- W2891882983 cites W2611004920 @default.
- W2891882983 cites W2612430336 @default.
- W2891882983 cites W2626892226 @default.
- W2891882983 cites W2688500010 @default.
- W2891882983 cites W2761237722 @default.
- W2891882983 cites W2763960561 @default.
- W2891882983 cites W2764340845 @default.
- W2891882983 cites W2765132620 @default.
- W2891882983 cites W2765695907 @default.
- W2891882983 cites W2767256995 @default.
- W2891882983 cites W2767761069 @default.
- W2891882983 cites W2768845394 @default.
- W2891882983 cites W2772566228 @default.